Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

101 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-01-31

Study Completion Date

2007-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected Adults

NCT00331448

HIV Infections Lipodystrophy Diabetes +2 more

UNKNOWN

Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

NCT00656851

HIV Infections Cardiovascular Disease Insulin Resistance +2 more

COMPLETED NA

The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients

NCT00001102

HIV Infections

COMPLETED

Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia

NCT00246376

Cardiovascular Diseases Heart Diseases HIV Infections +4 more

COMPLETED NA

Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy

NCT00000883

Mycobacterium Avium-intracellulare Infection HIV Infections

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This research is being done to learn whether HIV-infected patients have abnormalities in their blood vessels that could eventually lead to heart attack or stroke (atherosclerosis), in how fat is distributed in their body and in how their body handles fat and sugars. If there are abnormalities, this study will also try to find out what factors may contribute to those abnormalitites.

People who participated in FRAM 1 may join FRAM 2.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Immunodeficiency Virus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HIV Positive FRAM 1 Participant

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-65 years old
* previous FRAM 1 participant
* HIV positive

Exclusion Criteria

* Artificial knee or hip replacement or Harrington rod
* Metal objects in the body.Pregnancy
* Breastfeeding or less than 3 months after breastfeeding
* Weight more than 300 pound
* On insulin, pancreatic enzymes, or thioridazine.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No